- Home
- MMYT vs MRNA Comparison
MMYT vs MRNA Comparison
Compare MMYT & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMYT
- MRNA
- Stock Information
- Founded
- MMYT 2000
- MRNA 2010
- Country
- MMYT India
- MRNA United States
- Employees
- MMYT N/A
- MRNA N/A
- Industry
- MMYT Transportation Services
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMYT Consumer Discretionary
- MRNA Health Care
- Exchange
- MMYT Nasdaq
- MRNA Nasdaq
- Market Cap
- MMYT 11.3B
- MRNA 10.6B
- IPO Year
- MMYT 2010
- MRNA 2018
- Fundamental
- Price
- MMYT $92.29
- MRNA $25.90
- Analyst Decision
- MMYT Strong Buy
- MRNA Hold
- Analyst Count
- MMYT 2
- MRNA 19
- Target Price
- MMYT $127.50
- MRNA $48.13
- AVG Volume (30 Days)
- MMYT 1.5M
- MRNA 10.5M
- Earning Date
- MMYT 07-22-2025
- MRNA 07-31-2025
- Dividend Yield
- MMYT N/A
- MRNA N/A
- EPS Growth
- MMYT N/A
- MRNA N/A
- EPS
- MMYT 0.83
- MRNA N/A
- Revenue
- MMYT $978,336,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- MMYT $25.01
- MRNA N/A
- Revenue Next Year
- MMYT $21.01
- MRNA $9.87
- P/E Ratio
- MMYT $113.77
- MRNA N/A
- Revenue Growth
- MMYT 25.02
- MRNA N/A
- 52 Week Low
- MMYT $76.95
- MRNA $23.15
- 52 Week High
- MMYT $123.00
- MRNA $138.07
- Technical
- Relative Strength Index (RSI)
- MMYT 41.91
- MRNA 46.10
- Support Level
- MMYT $87.71
- MRNA $25.06
- Resistance Level
- MMYT $102.00
- MRNA $28.72
- Average True Range (ATR)
- MMYT 3.33
- MRNA 1.18
- MACD
- MMYT -0.64
- MRNA -0.18
- Stochastic Oscillator
- MMYT 48.19
- MRNA 20.34
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.